C.T. Fitzpatrick
Vulcan Value Partners
Vulcan Value Partners Core Laboratories NV stake
total: 273
Vulcan Value Partners CLB trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2015 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2015 Q4
According to 2026 Q2 report, Vulcan Value Partners doesn't hold any Core Laboratories NV (CLB) shares. To date, the estimated cost basis is nearly $99.8 for "buy" trades and estimated average "sell" price is $99.8. Vulcan Value Partners first purchased CLB in 2015 Q3, initially acquiring 171,164 shares. Since the initial investment in Core Laboratories NV (CLB), Vulcan Value Partners has made 1 more transaction.
When did Vulcan Value Partners sell Core Laboratories NV (CLB)?
Vulcan Value Partners sold off the entire Core Laboratories NV (CLB) position in 2015 Q4.
When did Vulcan Value Partners buy Core Laboratories NV (CLB)?
Vulcan Value Partners first invested in Core Laboratories NV (CLB) in 2015 Q3 at the reported quarter-end price of $99.80 per share.
What's the cost basis of Vulcan Value Partners's CLB stake?
The estimated cost basis for Core Laboratories NV (CLB) stake is around $99.80 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $99.80
- Weighted AVG sell price:
- $99.80
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.